ALTME.PA
TME Pharma NV
Price:  
0.07 
EUR
Volume:  
226,851.00
Germany | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALTME.PA WACC - Weighted Average Cost of Capital

The WACC of TME Pharma NV (ALTME.PA) is 5.9%.

The Cost of Equity of TME Pharma NV (ALTME.PA) is 5.90%.
The Cost of Debt of TME Pharma NV (ALTME.PA) is 5.00%.

Range Selected
Cost of equity 5.10% - 6.70% 5.90%
Tax rate 25.90% - 27.10% 26.50%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.1% - 6.7% 5.9%
WACC

ALTME.PA WACC calculation

Category Low High
Long-term bond rate 3.0% 3.5%
Equity market risk premium 5.8% 6.8%
Adjusted beta 0.37 0.4
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.10% 6.70%
Tax rate 25.90% 27.10%
Debt/Equity ratio 0.02 0.02
Cost of debt 5.00% 5.00%
After-tax WACC 5.1% 6.7%
Selected WACC 5.9%